Biomedical subjects

H R Millar

Publications and source records attributed to H R Millar.

4 recordsLinked to original sources

PubMed1990

Eating disorders, perceived control, assertiveness and hostility.

There are anecdotal claims that eating disorder patients perceive themselves as highly controlled by the family and by society, but that they do not show assertive behaviour towards controllers. Anorexic and bulimic females were compared with female psychiatric patients, dieters and non-dieting controls on measures of eating disorder symptomatology, locus of control, assertiveness, inwardly directed hostility, family control and family encouragement of independence. Eating disorder patients reported significantly more external control, more inwardly directed hostility, less self-assertion and less family encouragement of independence than dieters and non-dieting controls, but they did not differ from psychiatric controls. Most of the characteristics seen in eating disorder subjects were also reported by psychiatric controls.

Adolescent↗

PubMed1985

Anorexia nervosa in Glasgow.

A case note review of referrals to psychiatrists in Glasgow for 1979-1983 yielded 122 patients. Demographic and clinical data are described and compared to findings in earlier British series. Social class distribution for the Glasgow patients was no different from that of the local general population. This finding contrasted with the upper social class bias found in earlier studies and possible reasons for this difference are discussed.

Adolescent↗

PubMed1977

Prevention of adverse drug interactions.

1 The awareness and recognition of adverse interactions between drugs by prescribers is low. 2 A 6-month prospective study on patients on long-term outpatient anticoagulant therapy in the Grampian area has been carried out to evaluate a simple and cheap warning system. 3 The practitioners of patients in the test group were issued with warning labels which showed drugs known to interact. A reduction in the initiation of prescriptions for potentially interacting drugs was shown between the test and control groups (no warning labels). 4 The 140 practitioners who completed the study found the system to be convenient and useful. Extension to other high-risk drugs with the potential to interact with other drugs is planned. This system has the advantage of being drug and patient-orientated whereas lists of drug interactions or drug discs require more conscious effort by the prescriber.

Barbiturates↗

PubMed1976

Methyldopa and propranolol or practolol in moderate hypertension.

The effect of a low dose of methyldopa combined with (a) a non-selective and (b) a selective beta-adrenoceptor antagonist was studied in a double-blind crossover trial in 24 carefully selected patients with moderate hypertension (mean initial lying blood pressure 189/117 mm Hg). Each patient received methyldopa 750 mg/day, propranolol 240 mg/day, practolol 600 mg/day, methyldopa 750 mg/day combined with propranolol 240 mg/day, methyldopa 750 mg/day combined with practolol 600 mg/day, and placebo for four weeks each according to a random sequence. After four weeks of therapy the most effective treatment, methyldopa combined with propranolol, reduced lying and standing blood pressures by 36-5/21-4 mm Hg and 44-7/25 mm Hg respectively. Thic combination had similar effects to those of the combination of methyldopa with the cardioselective agent practolol except that it reduced lying diastolic pressure further. The combination was more effective than either treatment alone. No significant differences were found between the effects of propranolol, practolol, or methyldopa at the doses used.

Adult↗